Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
11:30:40 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.4400 USD | +46.67% |
|
+2.33% | -35.31% |
| Market Cap | 1.27M 1.13M 1.05M 948K 1.77M 120M 1.8M 12.59M 4.99M 63.09M 4.76M 4.66M 199M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.59M -1.42M -1.31M -1.19M -2.22M -151M -2.26M -15.75M -6.24M -78.9M -5.95M -5.83M -249M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +46.67% | ||
| 1 week | +2.33% | ||
| Current month | +10.00% | ||
| 1 month | +22.22% | ||
| 3 months | +69.23% | ||
| 6 months | -20.00% | ||
| Current year | -35.31% |
| 1 week | 0.35 |  | 0.44 |
| 1 month | 0.27 | | 0.49 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 38.25 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/2/26 | Free | Company | 111,209 | 3.4934% | ||
| 3/31/25 | Free | Company | 33,724 | 1.6419% | ||
| 12/31/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +46.67% | +2.33% | -38.04% | -99.02% | 1.27M | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +4.91% | +2.17% | +40.75% | +131.89% | 38.31B | |
| Weighted average by Cap. | +0.39% | +2.73% | +47.57% | +158.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.25 1.16 1.05 1.96 133.28 2 13.94 5.52 69.83 5.27 5.16 220.16 |
| Net income | -11.65M -10.41M -9.61M -8.71M -16.3M -1.11B -16.57M -116M -45.8M -580M -43.73M -42.8M -1.83B | -2.91M -2.6M -2.4M -2.17M -4.07M -276M -4.14M -28.88M -11.43M -145M -10.92M -10.69M -456M |
| Net Debt | -2.59M -2.32M -2.14M -1.94M -3.63M -246M -3.69M -25.75M -10.2M -129M -9.74M -9.53M -407M | -2.86M -2.55M -2.36M -2.13M -3.99M -271M -4.06M -28.34M -11.22M -142M -10.71M -10.49M -448M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$0.3850 | -4.75% | 234 |
| 26-10-20 | US$0.4042 | -6.00% | 104 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
